Chronic stress triggers real biological changes that may speed up cancer progression and weaken the body’s ability to respond to treatment, according to a new research review.
Stress is a common experience for many people with cancer. It can start at diagnosis, build during treatment, and sometimes linger even after therapy ends. Recent research from Wroclaw Medical University sheds light on how ongoing stress can set off biological changes that influence cancer’s development and how patients respond to care.
When the Body’s Defenses Stay on High Alert
Chronic stress is more than just a few days of worry. Researchers describe it as a long-term strain that keeps the body’s stress systems working overtime. This means the body remains on high alert for weeks or months, which can have real effects on health.
For people with cancer, stress isn’t just about worry or sadness. It can involve changes in work, family life, and self-identity. The research team looked at breast, prostate, pancreatic, and ovarian cancers, finding patterns that link stress to the body’s internal systems.
They identified three main biological stages that happen when stress goes unchecked. First, there’s a hormonal reaction. The body’s stress system, called the hypothalamic-pituitary-adrenal axis, becomes very active.
As the researchers put it, “The body acts as if it were constantly in danger mode. This is associated with increased inflammation and immunosuppression, which can promote tumor progression and weaken the response to treatment.” This leads to higher levels of hormones like cortisol and adrenaline, which don’t return to normal as they should. Over time, this can start to wear down the body’s natural defenses.
The Hidden Changes Affecting Tumors
The next stage involves the immune system. Stress hormones like cortisol can weaken the body’s ability to recognize and attack cancer cells. At the same time, they can raise inflammation, creating an environment where cancer cells can survive and multiply more easily.
This ongoing inflammation can also make treatments less effective. Researchers found that chronic stress can influence how tumors grow, including helping them form new blood vessels and making cancer cells more likely to spread.
Still, the review notes that it’s hard to separate the effects of stress from other factors, such as the severity of the disease or the treatments patients receive. While the biological links are clear in lab studies, proving them in real-world settings is more complex.
Why Stress Affects Cancers in Different Ways
Not all cancers respond to stress in the same way. The impact of stress depends on the type of cancer and the patient’s outlook. For example, breast and prostate cancers often have higher survival rates, and patients may face stress from long-term uncertainty and fear of recurrence.
In these cases, stress hormones like noradrenaline and cortisol seem to play a bigger role in how the cancer behaves, especially in the risk of spreading and how the body responds to treatment. The research suggests that while stress doesn’t always block treatment, it can add another challenge for some patients.
For cancers with lower survival rates, such as pancreatic and ovarian cancer, stress can be even more intense and may even show up before diagnosis. This points to biological factors at work, not just emotional reactions. In these cases, inflammation and certain immune markers, like IL-6, are more pronounced, which can further strain the body during treatment.
As the researchers note, “Psychological distress is not just an emotion, but a factor that can contribute to physiological overload of the body and reduce the reserves necessary for the treatment process.”
What Happens When Patients Get Support
There is some good news: psychological support can help. The review found that psychotherapy and similar approaches do more than just provide comfort. They can lower stress and inflammation markers, such as cortisol and certain cytokines, and improve quality of life.
However, the researchers caution that the link between therapy and survival is not simple. “There is no simple correlation: psychotherapy = longer survival. We see real, measurable biological changes, but the current state of knowledge does not allow for clear conclusions regarding mortality.”
Another key point is that the benefits of therapy may fade after treatment ends. This suggests that ongoing support, rather than short-term help, might work better for people living with cancer.
What Cancer Teams Need to Know Next
The review highlights several challenges in current research, such as inconsistent ways of measuring stress and the difficulty of separating stress from the disease itself. Still, the main message is clear: chronic stress is not a personal weakness, but a clinical issue that deserves attention.
- Make psycho-oncology a routine part of cancer care.
- Screen patients for distress regularly and provide quick support when needed.
- Offer help for caregivers and partners, who also experience high stress.
- Develop digital tools and long-term strategies to keep therapy benefits going.
The authors state, “Psycho-oncology cannot be an add-on. Chronic stress should be treated as a modifiable risk factor in oncology, analyzed in the context of complex biological, psychological, and environmental interactions.”
By understanding how stress affects the body, cancer care teams can better support patients at every stage. Managing stress is not just about improving emotional well-being,it’s a step toward better overall health outcomes.
Source: News Medical